Brief: Lansen Pharmaceutical updates on approval for Zhejiang Starry Pharmaceutical IPO
17/02/2016 08:23
Feb 17 (Reuters) - Lansen Pharmaceutical Holdings Ltd 0503.HK : * Zhejiang Starry Pharmaceutical has obtained the approval from China securities regulatory commission * Says listing of starry is expected to take place in early March 2016 * Says approval for the initial public offering of its shares and listing on the Shanghai stock exchange * Company indirectly holds approximately 21.5% of the total issued shares in the capital of Starry * Upon completion of proposed offering, co expected to indirectly hold 16.1% of total issued shares in capital of Starry * Source text for Eikon ID:nHKS60VC89 ((For more news, please click here 0503.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year